The conference room settled into a hushed anticipation as Xavier Wellington, the President of Osborn Pharmaceutical and Biotech Group, adjusted his glasses and rose to present his report. With the quiet precision of a seasoned surgeon, Xavier exuded confidence—his tailored navy suit was immaculate, salt-and-pepper hair slicked back neatly, and sharp green eyes that seemed to absorb every detail in the room.
Arthur leaned back in his chair, gesturing for Xavier to begin. "Let's hear how our medical division is performing, Xavier."
With a tap on the table, various data points illuminated the holographic screens around them. "I'll kick things off with our flagship product: the AMHP-9 Emerald Rebirth Pod." The screens displayed stunning 3D schematics of the sleek oval-shaped pod that had transformed skin reconstruction globally.
